Similarly, in the control arm, any serious adverse events reported in the control group were more prevalent in women (21.7%) than in men (15.1%), although this difference did not reach statistical significance overall.
1
—
—
Similarly, in the control arm, any serious adverse events reported in the control group were more prevalent in women (21.7%) than in men (15.1%), although this difference did not reach statistical significance overall.